1. A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
    Qianghua Yuan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  2. Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis
    Bernardo Rodriguez-Iturbe et al, 2022, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology CrossRef
  3. Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond
    Wei Yu et al, 2023, Reviews in Endocrine and Metabolic Disorders CrossRef
  4. Bi Xie Fen Qing Yin decoction alleviates potassium oxonate and adenine induced-hyperuricemic nephropathy in mice by modulating gut microbiota and intestinal metabolites
    Xianghao Lin et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  5. SLC2A9 rs1014290 Polymorphism is Associated with Prediabetes and Type 2 Diabetes
    Xuemei Zhang et al, 2022, International Journal of Endocrinology CrossRef
  6. Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
    Hao-lu Sun et al, 2021, Frontiers in Pharmacology CrossRef
  7. A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
    Yuqing Zhou et al, 2023, Nutrients CrossRef
  8. Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway
    Wei Gu et al, 2022, European Journal of Pharmacology CrossRef
  9. Adiposity Reduction by Cucumis melo var. gaettongchamoe Extract in High-Fat Diet-Induced Obese Mice
    Sun Young Park et al, 2023, Nutrients CrossRef
  10. A review on the fruit components affecting uric acid level and their underlying mechanisms
    Fengmao Zou et al, 2021, Journal of Food Biochemistry CrossRef
  11. Effect of Aerobic Treadmill Exercise Regulating Glucose Transporter 9 on Renal Function in Hyperuricemia Rats
    Jiarong LIANG et al, 2022, Rehabilitation Medicine CrossRef
  12. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
    Hidekatsu Yanai et al, 2024, Cells CrossRef
  13. TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter
    Xin Sun et al, 2023, Frontiers in Pharmacology CrossRef
  14. Obese female mice do not exhibit overt hyperuricemia despite hepatic steatosis and impaired glucose tolerance
    Sara E. Lewis et al, 2022, Advances in Redox Research CrossRef
  15. New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds
    Bendong Yang et al, 2022, Frontiers in Pharmacology CrossRef